课题基金 / 基金详情

MECHANISM OF ACTION OF NUCLEOSIDE ANALOGS

MECHANISM OF ACTION OF NUCLEOSIDE ANALOGS
核苷类似物的作用机制
批准号:
6563810
负责人:
WILLIAM B PARKER
金额:
$22.84万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-02-01 至 2003-01-31

项目摘要

项目成果

WILLIAM B PARKER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
APPLICANT'S DESCRIPTION (provided by Applicant) The overall goal of the program project is to design and synthesize new drugs for the treatment of cancer. The goal of this "Mechanism of action of nucleoside analogs" is to perform experiments to characterize the biochemical pharmacology of the new compounds that will be synthesized in projects 2 and 4. The information that will be gained about the mechanism of action of these compounds is vital to the rational development of these compounds as anticancer agents. In addition, this information will be provided to the organic chemists in projects 2 and 4 during regular group meetings to be used in the rational design of new agents. This project has 3 specific aims. In the first aim we will evaluate all compounds for toxicity to CEM cells to identify active and inactive agents. In the second aim we will perform biochemical experiments on selected compounds to gain a preliminary understanding of their mechanism of action. In the third aim, we will perform extensive studies on compounds that warrant a more thorough evaluation. Studies are planned to characterize in detail the mechanism of action of 2 agents that have demonstrated excellent in vivo antitumor activity, 4'-thio-arabinofuranosylcytosine and 2-Cl-2'-F-2'-deoxy- arabinofuranosyladenine (Clofarabine). These studies should lead to a comprehensive understanding of the mechanism of action of new agents that will aid in their development by determining how these compounds differ form existing anticancer drugs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2013 Nucleosides, Nucleotides, and Oligonucleotides Gordon Research Conference
  • 批准号:
    8519771
  • 项目类别:
  • 资助金额:
    $0.5万
  • 财政年份:
    2013
  • 负责人:
    WILLIAM B PARKER
  • 依托单位:
2011 Nucleosides, Nucleotides, and Oligonucleotides GRC
  • 批准号:
    8116777
  • 项目类别:
  • 资助金额:
    $0.35万
  • 财政年份:
    2011
  • 负责人:
    WILLIAM B PARKER
  • 依托单位:
Purine Analog Anti-Mycobacterial Drug Development
  • 批准号:
    7232669
  • 项目类别:
  • 资助金额:
    $46.37万
  • 财政年份:
    1999
  • 负责人:
    WILLIAM B PARKER
  • 依托单位:
PURINE ANALOG ANTIMYCOBACTERIAL DRUG DEVELOPMENT
  • 批准号:
    2797353
  • 项目类别:
  • 资助金额:
    $37.74万
  • 财政年份:
    1999
  • 负责人:
    WILLIAM B PARKER
  • 依托单位:
海外基金